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Abstract 
 
Purpose 
  Arginine methylation is catalyzed by protein arginine methyltransferases (PRMTs) and 
participates in a variety of cellular processes such as signal transduction, transcription, and 
translation. PRMTs are divided into three main types according to their catalytic activity. PRMT1 
is a type I PRMT that produces monomethyl arginine (MMA) and asymmetric dimethylarginine 
(ADMA), while PRMT5 is a type II PRMT that generates MMA and symmetric dimethylarginine 
(SDMA). Recently, it was reported that arginine methylation is closely related to heart diseases. 
Arginine methylation and PRMT1 levels are markedly disturbed in the diseased heart. However, 
the physiologic and pathophysiologic role of arginine methylation and PRMT1 is poorly understood 
and difficult to study in vivo due to early embryonic lethality in PRMT1 null mice. The aims of this 
study were to clarify the role of protein arginine methylation and its major enzyme PRMT1 in heart 
disease, and to evaluate the properties and molecular stability of each variant of murine PRMT5. 
 
Materials and Methods 
  Cardiomyocyte-specific PRMT1 deficient (PRMT1-cKO) mice were generated using the Cre-
loxP gene recombination system and Myh6-Cre mice. As we reported previously, PRMT1-cKO 
mice exhibited dilated cardiomyopathy (DCM) which finally led to lethal heart failure at an early 
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stage of life. In my study, I established a ribosome profiling (Ribo-seq) strategy for monitoring the 
on-going translation of expressed mRNA in mammalian tissue. RNA-seq, Ribo-seq, and metabolic 
analysis were performed to monitor the global transcription, translation, and metabolite profiles in 
the hearts of PRMT1-cKO mice from the onset of DCM to heart failure. 
  Protein stability of PRMT5 in HEK293T cells was studied. Biotin tagged N-terminal sequence 
peptides of PRMT5 variant (v) 1 and v2 were synthesized and used to look for binding partners 
with the aid of the biotin-tagged pull-down assay and MALDI-TOF-MS. 
 
Results 
  One month after birth, PRMT1-cKO mice displayed respiratory abnormality and died suddenly. 
The heart-to-body weight ratio showed that the heart mass was significantly increased in PRMT1-
cKO mice compared with the wildtype group. The decline in cardiac systolic function of PRMT1-
cKO mice began within 4 weeks after birth and was worse at 6 weeks. The PRMT1-cKO mice had 
elevated levels of the heart failure markers, ANP and BNP, indicating they died from heart failure, 
and decreased level of Prmt5-v2 due to the absence of PRMT1, which affected the splicing of 
Prmt5. PRMT5-v2 is constantly degraded through both the ubiquitin proteasome system (UPS) and 
the autophagic-lysosomal pathway (ALP) in an N-terminal sequence-dependent manner. Many 
proteins such as SFPQ and eEf1A1 were identified as the binding partners with the N-terminal 
sequence of PRMT5-v2. 
  Both RNA-seq and Ribo-seq were performed on the hearts of wildtype (WT) and PRMT1-cKO 
mice. In all, 3,080 genes and 740 genes were altered in RNA-seq and Ribo-seq, respectively. A gene 
ontology (GO) analysis of altered genes in three groups (RNA-seq only profile, RNA-seq-Ribo-seq 
overlapping profile, Ribo-seq only profile) suggested the presence of mitochondrial dysfunction 
and glutathione (GSH) metabolism disorder in the hearts of PRMT1-cKO mice. Metabolic analysis 
revealed the presence of abnormal GSH metabolism as well. 
 
Discussion 
  Currently, many research groups have generated tissue-specific PRMT1-deficient mice to 
elucidate the physiologic role of PRMT1 in vivo. In the present study, the PRMT1-cKO revealed 
that arginine methylation and PRMT1 are crucial to maintaining normal cardiac function. In the 
heart of PRMT1-cKO mice, the mRNA level of Prmt5-v2 was significantly reduced and the protein 
level of PRMT5 tended to increase while the level of SDMA, mainly produced by PRMT5, was 
markedly elevated. Proteins like eEf1A1 which binds to N-terminal of PRMT5-v2 might engage in 
PRMT5-v2 protein degradation. The imbalanced arginine methylation status might be the cause of 
DCM and heart failure as well. The pathogenesis of DCM and heart failure are complicated and not 
well understood. Global transcription, translation, and metabolic analysis may provide new insights 
into the molecular mechanism at the onset of heart diseases. PRMT1-cKO could be a novel DCM 
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and heart failure model for studying the pathogenesis of these diseases in humans. 
